CMS Should Ensure Medicare Drug Price Negotiations Benefit Cancer Patients and Protect Access to Innovative Cancer Therapies
The American Cancer Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN) sent a letter to the Centers for Medicare & Medicaid Services (CMS) offering recommendations that are unique to cancer to consider when implementing the negotiation provision of the Inflation Reduction Act.